Respuesta de los autores

  1. F.J. García-Martínez 1
  2. I. López-Martín 2
  3. J.C. Pascual 3
  1. 1 Clínica Universidad de Navarra, Madrid, España
  2. 2 Centro de Salud Soto del Real, Soto del Real, Madrid, España
  3. 3 Hospital General Universitario de Alicante, Alicante, España
Zugehörigkeit anzeigen +
Zeitschrift:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Datum der Publikation: 2017

Nummer: 8

Seiten: 596-597

Art: Artikel

DOI: 10.1016/J.SEMERG.2017.03.004 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Semergen: revista española de medicina de familia

Ziele für nachhaltige Entwicklung

Bibliographische Referenzen

  • J.M. Eirós, M. de Frutos Serna Hidrosadenitis supurativa: visión desde la Microbiología Semergen (2017), 10.1016/j.semerg.2017.02.005 View PDFGoogle Scholar
  • F.J. García-Martínez, J.C. Pascual, I. López-Martín, J.J. Pereyra-Rodríguez, A. Martorell Calatayud, L. Salgado-Boquete, et al. Actualización en hidrosadenitis supurativa en Atención Primaria Semergen, 43 (2017), pp. 34-42 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • E. Prens, I. Deckers Pathophysiology of hidradenitis suppurativa: An update J Am Acad Dermatol, 73 (5 Suppl 1) (2015), pp. S8-S11 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A.C. Jahns, H. Killasli, D. Nosek, B. Lundskog, A. Lenngren, Z. Muratova, et al. Microbiology of hidradenitis suppurativa (acne inversa): A histological study of 27 patients APMIS, 122 (2014), pp. 804-809 View PDFCrossRefView Record in ScopusGoogle Scholar
  • H.C. Ring, P. Riis Mikkelsen, I.M. Miller, H. Jenssen, K. Fuursted, D.M. Saunte, et al. The bacteriology of hidradenitis suppurativa: A systematic review Exp Dermatol, 24 (2015), pp. 727-731 View PDFCrossRefView Record in ScopusGoogle Scholar
  • C.C. Zouboulis, N. Desai, L. Emtestam, R.E. Hunger, D. Ioannides, I. Juhász, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa J Eur Acad Dermatol Venereol, 29 (2015), pp. 619-644 View PDFCrossRefView Record in ScopusGoogle Scholar
  • S. Kathju, L.A. Lasko, P. Stoodley Considering hidradenitis suppurativa as a bacterial biofilm disease FEMS Immunol Med Microbiol, 65 (2012), pp. 385-389 View PDFCrossRefView Record in ScopusGoogle Scholar
  • A. Martorell, F.J. García-Martínez, D. Jiménez-Gallo, J.C. Pascual, J. Pereyra-Rodriguez, L. Salgado, et al. Actualización en hidradenitis supurativa (I): epidemiología, aspectos clínicos y definición de severidad de la enfermedad Actas Dermosifiliogr, 106 (2015), pp. 703-715 ArticleDownload PDFGoogle Scholar
  • L. Gill, M. Williams, I. Hamzavi Update on hidradenitis suppurativa: Connecting the tracts F1000Prime Rep., 6 (2014), p. 112 View PDFView Record in ScopusGoogle Scholar
  • N. Scheinfeld Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system Dermatol Online J, 22 (2016) doj_31313 Google Scholar
  • H.H. van der Zee, J. Boer, E.P. Prens, G.B. Jemec The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa Dermatology, 219 (2009), pp. 143-147 View PDFCrossRefView Record in ScopusGoogle Scholar
  • G. Gener, F. Canoui-Poitrine, J.E. Revuz, O. Faye, F. Poli, G. Gabison, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: A series of 116 consecutive patients Dermatology, 219 (2009), pp. 148-154 View PDFCrossRefView Record in ScopusGoogle Scholar
  • O. Join-Lambert, F. Ribadeau-Dumas, V. Jullien, M.D. Kitzis, J.P. Jais, H. Coignard-Biehler, et al. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination Eur J Dermatol, 24 (2014), pp. 94-95 View Record in ScopusGoogle Scholar
  • O. Join-Lambert, H. Coignard, J.P. Jais, H. Guet-Revillet, S. Poirée, S. Fraitag, et al. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa Dermatology, 222 (2011), pp. 49-58 View PDFCrossRefView Record in ScopusGoogle Scholar
  • L. Matusiak, A. Bieniek, J.C. Szepietowski Bacteriology of hidradenitis suppurativa - Which antibiotics are the treatment of choice? Acta Derm Venereol, 94 (2014), pp. 699-702 View PDFCrossRefView Record in ScopusGoogle Scholar
  • S. Hessam, M. Sand, D. Georgas, A. Anders, F.G. Bechara Microbial profile and antimicrobial susceptibility of bacteria found in inflammatory hidradenitis suppurativa lesions Skin Pharmacol Physiol, 29 (2016), pp. 161-167 View PDFCrossRefView Record in ScopusGoogle Scholar
  • A.H. Fischer, A. Haskin, G.A. Okoye Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa J Am Acad Dermatol, 76 (2017), pp. 309-313 Google Scholar
  • N. Scheinfeld Extensive hidradenitis suppurativa (HS) Hurley stage iii disease treated with intravenous (IV) linezolid and meropenem with rapid remission Dermatol Online J., 21 (2015) doj_25709 Google Scholar
  • O. Join-Lambert, H. Coignard-Biehler, J.P. Jais, M. Delage, H. Guet-Revillet, S. Poirée, et al. Efficacy of ertapenem in severe hidradenitis suppurativa: A pilot study in a cohort of 30 consecutive patients J Antimicrob Chemother, 71 (2016), pp. 513-520 View PDFCrossRefView Record in ScopusGoogle Scholar
Fuente de los datos: Dialnet